ANI Pharmaceuticals, Inc. (ANIP)
82.71
+0.71
(+0.87%)
USD |
NASDAQ |
May 21, 16:00
82.71
0.00 (0.00%)
After-Hours: 19:59
ANI Pharmaceuticals Research and Development Expense (TTM) : 51.70M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Liquidia Corp. | 44.01M |
| Indivior Pharmaceuticals, Inc. | 67.00M |
| Phathom Pharmaceuticals, Inc. | 31.37M |
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| Assertio Holdings, Inc. | 1.706M |